The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0

作者：

Yilmaz, Musa ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Wang, Xuemei ^{[2
]}

Loghavi, Sanam ^{[3
]}

Khoury, Joseph ^{[3
]}

Jorgensen, Jeffrey ^{[3
]}

Ravandi, Farhad ^{[1
]}

Short, Nicholas ^{[1
]}

Cortes, Jorge ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan ^{[1
]}

Sasaki, Koji ^{[1
]}

Konopleva, Marina ^{[1
]}

Takahashi, Koichi ^{[1
]}

Wierda, William ^{[1
]}

Khouri, Maria ^{[1
]}

Jain, Nitin ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Estrov, Zeev ^{[1
]}

Bose, Prithviraj ^{[1
]}

Pierce, Sherry ^{[1
]}

Garris, Rebecca ^{[1
]}

O'Brien, Susan ^{[4
]}

Jabbour, Elias ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;

D O I：

10.1016/j.clml.2019.07.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-280

引用

页码：S193 / S194

页数：2

共 50 条

[41] Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment
U J Scheuring
H Pfeifer
B Wassmann
P Brück
B Gehrke
E K Petershofen
H Gschaidmeier
D Hoelzer
O G Ottmann
Leukemia, 2003, 17 : 1700 - 1706
[42] A Multicenter Analysis of Allogeneic Transplant Outcomes Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission
Rahman, Zaid Abdel
Othman, Tamer
Saliba, Rima M.
Vanegas, Yenny Alejandra Moreno
Mohty, Razan
Ledesma, Celina
Rondon, Gabriela
Jain, Nitin
Jabbour, Elias
Pullarkat, Vinod
Alkhateeb, Hassan B.
Kantarjian, Hagop M.
Greipp, Patricia T.
Nakamura, Ryotaro
Kharfan-Dabaja, Mohamed A.
Champlin, Richard E.
Forman, Stephen J.
Shpall, Elizabeth J.
Litzow, Mark R.
Foran, James M.
Aldoss, Ibrahim
Koller, Paul B.
Kebriaei, Partow
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (12): : 1197 - 1205
[43] Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
King, Amber C.
Pappacena, Jeremy J.
Tallman, Martin S.
Park, Jae H.
Geyer, Mark B.
LEUKEMIA RESEARCH, 2019, 79 : 27 - 33
[44] Linkage of cell division cycle 42 with clinical features, treatment response and survival in adult Philadelphia chromosome negative acute lymphoblastic leukemia
Chen, Qi
Zhu, Xiaoling
He, Di
Ding, Wanbao
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2024, 84 (03) : 139 - 146
[45] Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment
Scheuring, UJ
Pfeifer, H
Wassmann, B
Brück, P
Gehrke, B
Petershofen, E
Gschaidmeier, H
Hoelzer, D
Ottmann, OG
LEUKEMIA, 2003, 17 (09) : 1700 - 1706
[46] Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis
Shopsowitz, Kevin E.
Liu, Lorraine
Setiadi, Audi
Al-Bakri, Maryam
Vercauteren, Suzanne
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2022, 102 (05) : 342 - 352
[47] Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease
van Wering, ER
Van der Linden-Schrever, BEM
Szczepanski, T
Willemse, MJ
Baars, EA
Van Wijngaarde-Schmitz, HM
Kamps, WA
Van Dongen, JJM
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 139 - 146
[48] OVER EXPRESSION OF THE FATTY ACID SYNTHASE IS A STRONG PREDICTOR OF POOR PROGNOSIS AND CONTRIBUTES TO GLUCOCORTICOID RESISTANCE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Dehghan-Nayeri, N.
Gharehbaghian, A.
Pour, K. Goudarzi
Eshghi, P.
WORLD CANCER RESEARCH JOURNAL, 2016, 3 (03)
[49] Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia
Shen, Hong-Qiang
Feng, Jian-Hua
Tang, Yong-Min
Song, Hua
Yang, Shi-Long
Shi, Shu-Wen
Xu, Wei-Qun
LEUKEMIA RESEARCH, 2013, 37 (06) : 671 - 674
[50] A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
Khan, Sharif S.
Mori, Shahram
Jeyakumar, Deepa
Keng, Michael Kenneth
Murthy, Hemant S.
Bar-Natan, Michal
Gundabolu, Krishna
O'Dwyer, Kristen
Rodriguez, Tulio
Stein, Anthony Selwyn
Oliai, Caspian
McCann, Christopher
Zaman, Faraz
Zugmaier, Gerhard
Gordon, Paul
Pardee, Timothy S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S266 - S266

← 1 2 3 4 5 →